Matches in SemOpenAlex for { <https://semopenalex.org/work/W2046235923> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2046235923 endingPage "1312" @default.
- W2046235923 startingPage "1309" @default.
- W2046235923 abstract "In community-wide immunisation programmes against childhood infections there is a conflict between the interests of the individual (vaccine safety and efficacy) and the interests of the community (vaccine uptake and level of herd immunity). Studies suggesting that the complication rate is greater with the high efficacy Urabe Am 9 mumps vaccine than with the lower efficacy Jeryl Lynn vaccine, have led to concern about whether the higher efficacy mumps vaccine should be introduced or retained in nationwide mass immunisation programmes.We describe the use of a mathematical model to assess benefits and risks to both individual and community, and illustrate this method by reference to immunisation programmes based on these vaccines. On the basis of current epidemiological data on viral transmission and vaccine coverage in England and Wales, data on vaccine-associated and infection-associated complication rates, and vaccine efficacies estimated from clinical trials, our analyses suggest there is little to chose between the two vaccines, but that overall performance depends on the level of vaccine coverage in a defined population. In community-based programmes, the greater apparent safety of the Jeryl Lynn vaccine (fewer vaccine-included complications) is offset by the greater apparent efficacy of the Urabe Am 9 vaccine (fewer complications due to natural infection).The findings suggest that it may not always be in the interests of the community to use the vaccine with the lowest complication rate." @default.
- W2046235923 created "2016-06-24" @default.
- W2046235923 creator A5049396774 @default.
- W2046235923 creator A5087452041 @default.
- W2046235923 date "1991-11-01" @default.
- W2046235923 modified "2023-10-17" @default.
- W2046235923 title "Vaccine safety versus vaccine efficacy in mass immunisation programmes" @default.
- W2046235923 cites W1961697991 @default.
- W2046235923 cites W1970947879 @default.
- W2046235923 cites W1972275995 @default.
- W2046235923 cites W1974744867 @default.
- W2046235923 cites W1993904284 @default.
- W2046235923 cites W2005618885 @default.
- W2046235923 cites W2010097096 @default.
- W2046235923 cites W2012980497 @default.
- W2046235923 cites W2016630280 @default.
- W2046235923 cites W2019029009 @default.
- W2046235923 cites W2028024634 @default.
- W2046235923 cites W2037487337 @default.
- W2046235923 cites W2095078971 @default.
- W2046235923 cites W2128581888 @default.
- W2046235923 cites W2143698733 @default.
- W2046235923 cites W2146014146 @default.
- W2046235923 cites W2148029848 @default.
- W2046235923 cites W2151121425 @default.
- W2046235923 cites W2409851025 @default.
- W2046235923 cites W2415138800 @default.
- W2046235923 cites W89066223 @default.
- W2046235923 doi "https://doi.org/10.1016/0140-6736(91)92601-w" @default.
- W2046235923 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1682694" @default.
- W2046235923 hasPublicationYear "1991" @default.
- W2046235923 type Work @default.
- W2046235923 sameAs 2046235923 @default.
- W2046235923 citedByCount "36" @default.
- W2046235923 countsByYear W20462359232014 @default.
- W2046235923 countsByYear W20462359232015 @default.
- W2046235923 countsByYear W20462359232020 @default.
- W2046235923 crossrefType "journal-article" @default.
- W2046235923 hasAuthorship W2046235923A5049396774 @default.
- W2046235923 hasAuthorship W2046235923A5087452041 @default.
- W2046235923 hasConcept C106192422 @default.
- W2046235923 hasConcept C187212893 @default.
- W2046235923 hasConcept C203014093 @default.
- W2046235923 hasConcept C22070199 @default.
- W2046235923 hasConcept C2776438120 @default.
- W2046235923 hasConcept C2776672420 @default.
- W2046235923 hasConcept C2780441014 @default.
- W2046235923 hasConcept C2780657872 @default.
- W2046235923 hasConcept C2908647359 @default.
- W2046235923 hasConcept C71924100 @default.
- W2046235923 hasConcept C99454951 @default.
- W2046235923 hasConceptScore W2046235923C106192422 @default.
- W2046235923 hasConceptScore W2046235923C187212893 @default.
- W2046235923 hasConceptScore W2046235923C203014093 @default.
- W2046235923 hasConceptScore W2046235923C22070199 @default.
- W2046235923 hasConceptScore W2046235923C2776438120 @default.
- W2046235923 hasConceptScore W2046235923C2776672420 @default.
- W2046235923 hasConceptScore W2046235923C2780441014 @default.
- W2046235923 hasConceptScore W2046235923C2780657872 @default.
- W2046235923 hasConceptScore W2046235923C2908647359 @default.
- W2046235923 hasConceptScore W2046235923C71924100 @default.
- W2046235923 hasConceptScore W2046235923C99454951 @default.
- W2046235923 hasIssue "8778" @default.
- W2046235923 hasLocation W20462359231 @default.
- W2046235923 hasLocation W20462359232 @default.
- W2046235923 hasOpenAccess W2046235923 @default.
- W2046235923 hasPrimaryLocation W20462359231 @default.
- W2046235923 hasRelatedWork W1990861298 @default.
- W2046235923 hasRelatedWork W2111358957 @default.
- W2046235923 hasRelatedWork W2127387725 @default.
- W2046235923 hasRelatedWork W2131782879 @default.
- W2046235923 hasRelatedWork W2142026573 @default.
- W2046235923 hasRelatedWork W3156627716 @default.
- W2046235923 hasRelatedWork W3157580658 @default.
- W2046235923 hasRelatedWork W3169034483 @default.
- W2046235923 hasRelatedWork W3198033394 @default.
- W2046235923 hasRelatedWork W4210638443 @default.
- W2046235923 hasVolume "338" @default.
- W2046235923 isParatext "false" @default.
- W2046235923 isRetracted "false" @default.
- W2046235923 magId "2046235923" @default.
- W2046235923 workType "article" @default.